Hayward, United States
Core Diagnostics USA is a California licensed CLIA certified laboratory providing biomarker analysis and translational research support. The company collaborates with clients to develop biomarker strategies and assays, offering services in histopathology, IHC, FISH, mutational analysis, and high-throughput gene expression studies. Core Diagnostics has implemented cutting-edge platforms for molecular analysis, including the nCounter® Analysis System from NanoString® and the BioMark™ HD System from Fluidigm for gene expression studies, the Allegro™ fluorescent imaging system and Solo™ workstation from BioView for FISH analysis, and the intelliPATH IHC platform from Biocare Medical.
Founded in 2011, Core Diagnostics USA offers support for studies ranging from early discovery to analyses of Phase III clinical trial samples, functioning seamlessly as an extension of their clients' teams. The company takes a technology agnostic approach and serves industry clients in the United States.
